Deep latency: A new insight into a functional HIV cure

作者: Maher M. Elsheikh , Yuyang Tang , Dajiang Li , Guochun Jiang

DOI: 10.1016/J.EBIOM.2019.06.020

关键词: In patientViral replicationGenome editingBioinformaticsMedicineBone marrow transplantationHuman immunodeficiency virus (HIV)Latency (engineering)Immune clearanceAntiretroviral therapy

摘要: Latent HIV reservoir is the main obstacle that prevents a cure for HIV-1 (HIV). While antiretroviral therapy effective in controlling viral replication, it cannot eliminate latent reservoirs patients. Several strategies have been proposed to combat latency, including bone marrow transplantation replace blood cells with CCR5-mutated stem cells, gene editing disrupt genome, and "Shock Kill" reactivate followed by an immune clearance. However, high risks limitations scale-up clinics, off-target effects human genomes or failure reduce sizes patients hampered our current efforts achieve cure. This necessitates alternative control reservoirs. review will discuss emerging strategy aimed deeply silence reservoirs, development of this concept, its potential caveats remission/cure, prospective directions silencing HIV, thereby preventing viruses from rebound.

参考文章(71)
Amanda M. Crooks, Rosalie Bateson, Anna B. Cope, Noelle P. Dahl, Morgan K. Griggs, JoAnn D. Kuruc, Cynthia L. Gay, Joseph J. Eron, David M. Margolis, Ronald J. Bosch, Nancie M. Archin, Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies The Journal of Infectious Diseases. ,vol. 212, pp. 1361- 1365 ,(2015) , 10.1093/INFDIS/JIV218
Daniel A Donahue, Mark A Wainberg, Cellular and molecular mechanisms involved in the establishment of HIV-1 latency Retrovirology. ,vol. 10, pp. 11- 11 ,(2013) , 10.1186/1742-4690-10-11
Angela Battistini, Marco Sgarbanti, HIV-1 latency: an update of molecular mechanisms and therapeutic strategies. Viruses. ,vol. 6, pp. 1715- 1758 ,(2014) , 10.3390/V6041715
Laurence Lavie, Milena Kitova, Esther Maldener, Eckart Meese, Jens Mayer, CpG Methylation Directly Regulates Transcriptional Activity of the Human Endogenous Retrovirus Family HERV-K(HML-2) Journal of Virology. ,vol. 79, pp. 876- 883 ,(2005) , 10.1128/JVI.79.2.876-883.2005
Alexander S. Zevin, Lyle McKinnon, Adam Burgener, Nichole R. Klatt, Microbial translocation and microbiome dysbiosis in HIV-associated immune activation Current Opinion in Hiv and Aids. ,vol. 11, pp. 182- 190 ,(2016) , 10.1097/COH.0000000000000234
P. M. Feorino, S. T. Butera, T. M. Folks, R. F. Schinazi, Prevention of activation of HIV-1 by antiviral agents in OM-10.1 cells Antiviral Chemistry & Chemotherapy. ,vol. 4, pp. 55- 63 ,(1993) , 10.1177/095632029300400107
Javier Martinez-Picado, Steven G. Deeks, Persistent HIV-1 replication during antiretroviral therapy. Current Opinion in Hiv and Aids. ,vol. 11, pp. 417- 423 ,(2016) , 10.1097/COH.0000000000000287
D. M. Margolis, J. V. Garcia, D. J. Hazuda, B. F. Haynes, Latency reversal and viral clearance to cure HIV-1 Science. ,vol. 353, ,(2016) , 10.1126/SCIENCE.AAF6517
Ross A. Pollack, R. Brad Jones, Mihaela Pertea, Katherine M. Bruner, Alyssa R. Martin, Allison S. Thomas, Adam A. Capoferri, Subul A. Beg, Szu-Han Huang, Sara Karandish, Haiping Hao, Eitan Halper-Stromberg, Patrick C. Yong, Colin Kovacs, Erika Benko, Robert F. Siliciano, Ya-Chi Ho, Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host & Microbe. ,vol. 21, pp. 494- 506 ,(2017) , 10.1016/J.CHOM.2017.03.008